AMPK-upregulated microRNA-708 plays as a suppressor of cellular senescence and aging via downregulating disabled-2 and mTORC1 activation

© 2024 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd..

Senescence-associated microRNAs (SA-miRNAs) are important molecules for aging regulation. While many aging-promoting SA-miRNAs have been identified, confirmed aging-suppressive SA-miRNAs are rare, that impeded our full understanding on aging regulation. In this study, we verified that miR-708 expression is decreased in senescent cells and aged tissues and revealed that miR-708 overexpression can alleviate cellular senescence and aging performance. About the molecular cascade carrying the aging suppressive action of miR-708, we unraveled that miR-708 directly targets the 3'UTR of the disabled 2 (Dab2) gene and inhibits the expression of DAB2. Interestingly, miR-708-caused DAB2 downregulation blocks the aberrant mammalian target of rapamycin complex 1 (mTORC1) activation, a driving metabolic event for senescence progression, and restores the impaired autophagy, a downstream event of aberrant mTORC1 activation. We also found that AMP-activated protein kinase (AMPK) activation can upregulate miR-708 via the elevation of DICER expression, and miR-708 inhibitor is able to blunt the antiaging effect of AMPK. In summary, this study characterized miR-708 as an aging-suppressive SA-miRNA for the first time and uncovered a new signaling cascade, in which miR-708 links the DAB2/mTOR axis and AMPK/DICER axis together. These findings not only demonstrate the potential role of miR-708 in aging regulation, but also expand the signaling network connecting AMPK and mTORC1.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:5

Enthalten in:

MedComm - 5(2024), 3 vom: 27. März, Seite e475

Sprache:

Englisch

Beteiligte Personen:

Zhang, Jian [VerfasserIn]
Gong, Hui [VerfasserIn]
Zhao, Tingting [VerfasserIn]
Xu, Weitong [VerfasserIn]
Chen, Honghan [VerfasserIn]
Li, Tiepeng [VerfasserIn]
Yang, Yu [VerfasserIn]
Yang, Ming [VerfasserIn]
Huang, Ning [VerfasserIn]
Gong, Chuhui [VerfasserIn]
Wang, Fangfang [VerfasserIn]
Zhang, Cuiying [VerfasserIn]
Liu, Jin [VerfasserIn]
Xiao, Hengyi [VerfasserIn]

Links:

Volltext

Themen:

AMP‐activated protein kinase (AMPK)
Aging
Disabled 2 (DAB2)
Journal Article
Mammalian traget of rapamycin coplex 1 (mTORC1)
MiR‐708

Anmerkungen:

Date Revised 12.03.2024

published: Electronic-eCollection

Citation Status PubMed-not-MEDLINE

doi:

10.1002/mco2.475

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369531256